ERLOTINIB HYDROCHLORIDE

Product NDC
46708-566
11-digit product format
467080566
Labeler code
46708
Product ID
46708-566_966e67f7-6259-4b1c-8c6a-b2589d57e1ed
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ERLOTINIB HYDROCHLORIDE
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Alembic Pharmaceuticals Limited
Application
ANDA214719
Marketing category
ANDA
Marketing start
2021-07-09
Substance
ERLOTINIB HYDROCHLORIDE
Active strength
100 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
ERLOTINIB HYDROCHLORIDE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ERLOTINIB HYDROCHLORIDE100 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiDA87705X9K
Rxcui603203, 603206, 603208

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
bd23d1a5-e4ff-4f92-da3b-5034c014ad1aProduct name820250331

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
46708-566-30ERLOTINIB HYDROCHLORIDE30 in 1 BOTTLETABLET, FILM COATED303
46708-566-90ERLOTINIB HYDROCHLORIDE90 in 1 BOTTLETABLET, FILM COATED903

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
46708-566ERLOTINIB HYDROCHLORIDE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]3Current NDC, Legacy NDC, 2 package rows20240612_ab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
603203erlotinib 100 MG Oral TabletPSNab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b3
603206erlotinib 150 MG Oral TabletPSNab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b3
603208erlotinib 25 MG Oral TabletPSNab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b3
603203erlotinib 100 MG Oral TabletSCDab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b3
603206erlotinib 150 MG Oral TabletSCDab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b3
603208erlotinib 25 MG Oral TabletSCDab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b3
603208erlotinib (as erlotinib hydrochloride) 25 MG Oral TabletSYab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b3
603203erlotinib 100 MG (equivalent to erlotinib HCl 109.3 MG) Oral TabletSYab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b3
603206erlotinib 150 MG (equivalent to erlotinib HCl 163.9 MG) Oral TabletSYab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
46708-566-304670805663030 TABLET, FILM COATED in 1 BOTTLE (46708-566-30) 2021-07-090000-00-00NoNoCurrent
46708-566-904670805669090 TABLET, FILM COATED in 1 BOTTLE (46708-566-90) 2021-07-090000-00-00NoNoCurrent